Literature DB >> 19052451

Stage-independent and stage-specific phenotypic differences between vascular dementia and Alzheimer's Disease.

Mark Chan1, Wee Shiong Lim, Suresh Sahadevan.   

Abstract

AIMS: We examined the effect of stratification by dementia severity on clinical and neuropsychological differences observed between vascular dementia (VaD) and Alzheimer's disease (AD) to ascertain whether any observed phenotypic differences would differ between the early and late stages.
METHODS: The phenotypic features at presentation of 219 newly diagnosed VaD (n = 103) and AD (n = 116) patients were analyzed. All patients underwent clinical, neuropsychological and neuroimaging evaluation. Severity of dementia was staged using the Clinical Dementia Rating (CDR) scale.
RESULTS: VaD can be clinically distinguished from AD by criterion-related features that span across all stages of dementia. We also identified non-criterion-related features that differed according to dementia severity. In the CDR 0.5-1 stage, VaD patients demonstrated increased reading difficulty, loss of insight, apathy, and greater impairment in executive function compared with delayed and recognition memory. Unique distinguishing features for VaD in the CDR 2-3 stage included higher Geriatric Depression Scale scores, lower Barthel scores, gait apraxia and parkinsonism.
CONCLUSIONS: Phenotypic differences between VaD and AD can be conceptualized as either criterion-related stage-independent features, or stage-specific features (comprising cognitive and neuropsychological elements in the mild stages, and physical, affective and functional components in the later stages). Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 19052451     DOI: 10.1159/000178755

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  2 in total

1.  Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size.

Authors:  Gustavo C Román; Stephen Salloway; Sandra E Black; Donald R Royall; Charles Decarli; Michael W Weiner; Margaret Moline; Dinesh Kumar; Rachel Schindler; Holly Posner
Journal:  Stroke       Date:  2010-04-15       Impact factor: 7.914

2.  Apraxia for differentiating Alzheimer's disease from subcortical vascular dementia and mild cognitive impairment.

Authors:  Serhat Ozkan; Demet Ozbabalik Adapinar; Nese Tuncer Elmaci; Didem Arslantas
Journal:  Neuropsychiatr Dis Treat       Date:  2013-07-09       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.